| Application no. and date | 09726304.0 (espacenet) (Federated) (European Patent Register), 20090326 | | Patent/reg. no. and date | DK/EP 2271321, 20120613 | | Publication date | 20110112 | | Priority no. and date | US 40372, 20080328 | | EP pub. no. and date |
EP 2271321 20110112 | | Effective date | | | Applicant/owner | Array BioPharma Inc., 3200 Walnut Street
Boulder, CO 80301, US,
AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AST103271 | | Inventor | BATEMAN, Nicola, Frances, AstraZeneca
Charter Way
Macclesfield
Cheshire SK10 2NA, GB,
GELLERT, Paul, Richard, AstraZeneca R&D Alderley
Alderley Park
Macclesfield
Cheshire SK10 4TG, GB,
HILL, Kathryn, Jane, AstraZeneca R&D Alderley
Alderley Park
Macclesfield
Cheshire SK10 4TG, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/4184 (2006.01) , A61K 9/14 (2006.01) , A61K 9/48 (2006.01) , C07D 235/06 (2006.01) | | Title | Farmaceutisk sammensætning 271 | | Int. application no. | GB2009050293 | | Int. publication no. | WO2009118562 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
